Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Burks

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Review of Neurotherapeutics|April 28, 2005
Interferon-beta1b for multiple sclerosisJack Burks
Clinicoeconomics and Outcomes Research : CEOR|May 13, 2017
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosisJack Burks, Thomas S Marshall, Xiaolan Ye
International Journal of MS Care|March 6, 2015
Lower urinary tract symptom prevalence and management among patients with multiple sclerosisKristin M Khalaf, Karin S Coyne, Denise R Globe, et al.
Neurourology and Urodynamics|October 21, 2014
The impact of lower urinary tract symptoms on health-related quality of life among patients with multiple sclerosisKristin M Khalaf, Karin S Coyne, Denise R Globe, et al.
BMC Neurology|July 11, 2013
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening toolDavid Bates, Jack Burks, Denise Globe, et al.
International Journal of MS Care|January 24, 2014
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patientsJack Burks, Michael Chancellor, David Bates, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Review of Neurotherapeutics|April 28, 2005
Interferon-beta1b for multiple sclerosisJack Burks
Clinicoeconomics and Outcomes Research : CEOR|May 13, 2017
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosisJack Burks, Thomas S Marshall, Xiaolan Ye
International Journal of MS Care|March 6, 2015
Lower urinary tract symptom prevalence and management among patients with multiple sclerosisKristin M Khalaf, Karin S Coyne, Denise R Globe, et al.
Neurourology and Urodynamics|October 21, 2014
The impact of lower urinary tract symptoms on health-related quality of life among patients with multiple sclerosisKristin M Khalaf, Karin S Coyne, Denise R Globe, et al.
BMC Neurology|July 11, 2013
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening toolDavid Bates, Jack Burks, Denise Globe, et al.
International Journal of MS Care|January 24, 2014
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patientsJack Burks, Michael Chancellor, David Bates, et al.
Pageof 1